Opioid Crisis Resources

According to the Centers for Disease Control and Prevention (CDC), 91 people die every day from an opioid overdose. AANA is committed to taking action toward solutions to the opioid epidemic, with CRNAs playing a key role in the process.

AANA has developed and compiled resources and tools for patients and healthcare providers to support meaningful decision-making regarding acute and chronic pain management, opioid safety, substance use disorder, and more. Use the buttons below to navigate AANA's resources.

Breaking News and Alerts

Statement by FDA Commissioner Scott Gottlieb, M.D., on the agency’s ongoing work to forcefully address the opioid crisis, August 29, 2018

FDA takes action against 21 websites marketing unapproved opioids as part of agency’s effort to target illegal online sales, August 28, 2018

FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder, August 6, 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse, July 20, 2018

Rising numbers of deaths involving Fentanyl and Fentanyl analogs, including Carfentanil, and increased usage and mixing with non-opioids, July 11, 2018

FDA approves first generic versions of Suboxone sublingual film, which may increase access to treatment for opioid dependence, June 14, 2018

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults, May 16, 2018

U.S. Department of Health and Human Services' 5-Point strategy to combat the opioid crisis, May 15, 2018

FDA Voice - Addressing needs of patients while stemming the tide of the opioid crisis, May 14, 2018

Contact Us

Professional Practice
(847) 655-8870

​Health & Wellness
(847) 655-1114

Peer Assistance Helpline
(800) 654-5167


​​​The resources on this page may incorporate or summarize views, guidelines, or recommendations of third parties. Such material is assembled and presented in good faith, but does not necessarily reflect the views of the AANA. Links to third-party websites are inserted for informational purposes and do not constitute endorsement of the material on those sites, or of any associated organization.